These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18249005)

  • 1. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
    Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
    Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
    Gao J; Cha S; Jonsson R; Opalko J; Peck AB
    Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
    Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
    Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
    Cavill D; Waterman SA; Gordon TP
    Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
    Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
    Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications.
    Reina S; Sterin-Borda L; Orman B; Borda E
    J Neuroimmunol; 2004 May; 150(1-2):107-15. PubMed ID: 15081254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
    Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
    Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D; Waterman SA; Gordon TP
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
    Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
    J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
    Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
    Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
    J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
    Sumida T; Tsuboi H; Iizuka M; Asashima H; Matsumoto I
    Mod Rheumatol; 2013 Sep; 23(5):841-5. PubMed ID: 23135882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
    Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
    J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
    Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
    Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
    Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
    Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
    Namkoong E; Lee SW; Kim N; Choi Y; Park K
    Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-M3 muscarinic acetylcholine receptor antibodies and Sjögren's syndrome].
    Tsuboi H; Iizuka M; Asashima H; Sumida T
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):77-85. PubMed ID: 23629427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
    Tsuboi H; Matsumoto I; Wakamatsu E; Nakamura Y; Iizuka M; Hayashi T; Goto D; Ito S; Sumida T
    Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.